DPP-IV therapy Key takeaways: Older adults with type 2 diabetes have better CV outcomes when receiving an SGLT2 inhibitor or GLP-1 receptor agonist vs
Measuring Your Progress Tracking the right markers helps you understand how your insulin resistance is responding to treatment
Factors like age, hormonal status, existing medical conditions, and concurrent medications all influence both the likelihood and severity of GLP-1 related dry mouth
These are administered by occupational health clinics, third-party testing services, or employer-contracted collection sites
However, over the course of their first year on the medication, they shift their spending toward grocery foodservice, casual dining and midscale restaurants
Such information would be useful to the PBAC